103 related articles for article (PubMed ID: 26212664)
1. Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells.
Lee J; Hun Yun J; Lee J; Choi C; Hoon Kim J
Sci Rep; 2015 Jul; 5():12296. PubMed ID: 26212664
[TBL] [Abstract][Full Text] [Related]
2. Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A.
Lee J; Lee J; Yun JH; Choi C; Cho S; Kim SJ; Kim JH
Sci Rep; 2017 Oct; 7(1):12760. PubMed ID: 28986588
[TBL] [Abstract][Full Text] [Related]
3. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
Lee J; Lee J; Yun JH; Jeong DG; Kim JH
Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
[TBL] [Abstract][Full Text] [Related]
4. Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer.
Lee J; Lee J; Kim JH
Cancer Lett; 2019 Aug; 456():1-12. PubMed ID: 30902562
[TBL] [Abstract][Full Text] [Related]
5. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
6. DUSP28 promotes cell proliferation, migration, and invasion by Akt/β-catenin/Slug axis in breast cancer.
Zhang J; Guo Y
Acta Biochim Pol; 2022 Dec; 69(4):711-717. PubMed ID: 36520087
[TBL] [Abstract][Full Text] [Related]
7. DUSP28 contributes to human hepatocellular carcinoma via regulation of the p38 MAPK signaling.
Wang D; Han S; Peng R; Jiao C; Wang X; Han Z; Li X
Int J Oncol; 2014 Dec; 45(6):2596-604. PubMed ID: 25230705
[TBL] [Abstract][Full Text] [Related]
8. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer.
Yuan K; Yong S; Xu F; Zhou T; McDonald JM; Chen Y
Oncotarget; 2015 Sep; 6(28):25308-19. PubMed ID: 26320171
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
Wang P; Zhang J; Bellail A; Jiang W; Hugh J; Kneteman NM; Hao C
Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
[TBL] [Abstract][Full Text] [Related]
10. Expression of snail in pancreatic cancer promotes metastasis and chemoresistance.
Yin T; Wang C; Liu T; Zhao G; Zha Y; Yang M
J Surg Res; 2007 Aug; 141(2):196-203. PubMed ID: 17583745
[TBL] [Abstract][Full Text] [Related]
11. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
12. Metastin and its variant forms suppress migration of pancreatic cancer cells.
Masui T; Doi R; Mori T; Toyoda E; Koizumi M; Kami K; Ito D; Peiper SC; Broach JR; Oishi S; Niida A; Fujii N; Imamura M
Biochem Biophys Res Commun; 2004 Feb; 315(1):85-92. PubMed ID: 15013429
[TBL] [Abstract][Full Text] [Related]
13. Silencing Delta-like 1 Expression Induces Migratory Features in Pancreatic Cancer Cells Through Stimulation of Src and p38 Signalling Pathway.
Lee J; Lee J; Kim DH; Kim JH
Anticancer Res; 2020 Mar; 40(3):1335-1344. PubMed ID: 32132030
[TBL] [Abstract][Full Text] [Related]
14. Structural and biochemical analysis of atypically low dephosphorylating activity of human dual-specificity phosphatase 28.
Ku B; Hong W; Keum CW; Kim M; Ryu H; Jeon D; Shin HC; Kim JH; Kim SJ; Ryu SE
PLoS One; 2017; 12(11):e0187701. PubMed ID: 29121083
[TBL] [Abstract][Full Text] [Related]
15. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.
Fan Y; Gan Y; Shen Y; Cai X; Song Y; Zhao F; Yao M; Gu J; Tu H
Oncotarget; 2015 Jun; 6(18):16120-34. PubMed ID: 25948792
[TBL] [Abstract][Full Text] [Related]
16. Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells.
Rivera IG; Ordoñez M; Presa N; Gangoiti P; Gomez-Larrauri A; Trueba M; Fox T; Kester M; Gomez-Muñoz A
Biochem Pharmacol; 2016 Feb; 102():107-119. PubMed ID: 26707801
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro.
Lee J; Kim JH
PLoS One; 2016; 11(5):e0155264. PubMed ID: 27175782
[TBL] [Abstract][Full Text] [Related]
18. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
[TBL] [Abstract][Full Text] [Related]
19. Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo.
Gomes EG; Connelly SF; Summy JM
Pancreas; 2013 Jul; 42(5):795-806. PubMed ID: 23271399
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer.
Schlingensiepen KH; Jaschinski F; Lang SA; Moser C; Geissler EK; Schlitt HJ; Kielmanowicz M; Schneider A
Cancer Sci; 2011 Jun; 102(6):1193-200. PubMed ID: 21366804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
